XML 55 R83.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Consolidating Financial Statements - Cash Flows (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Jul. 26, 2014
Jul. 27, 2013
Jul. 28, 2012
Jul. 26, 2014
Parent
Jul. 27, 2013
Parent
Jul. 28, 2012
Parent
Jul. 26, 2014
Issuer
Jul. 27, 2013
Issuer
Jul. 28, 2012
Issuer
Jul. 26, 2014
Subsidiary Guarantors
Jul. 27, 2013
Subsidiary Guarantors
Jul. 28, 2012
Subsidiary Guarantors
Jul. 26, 2014
Non-Guarantor Subsidiaries
Jul. 27, 2013
Non-Guarantor Subsidiaries
Jul. 28, 2012
Non-Guarantor Subsidiaries
Jul. 26, 2014
Eliminations and Reclassifications
Jul. 27, 2013
Eliminations and Reclassifications
Jul. 28, 2012
Eliminations and Reclassifications
Condensed Financial Statements, Captions [Line Items]                                    
Debt premium $ 3,200 $ 0                                
Net cash provided by operating activities 84,185 106,744 65,125 7,199 6,952 6,755 (12,242) (9,612) (8,774) 93,898 112,176 69,823 (4,670) (2,772) (2,679) 0 0 0
Cash flows from investing activities:                                    
Cash paid for acquisition, net of cash acquired (17,088) (330,291) 0 0 0   0 0   (16,388) (330,291)   (700) 0   0 0  
Capital expenditures (89,136) (64,650) (77,612) (8,541) (8,151) (3,685) 0 0 0 (72,962) (51,647) (69,362) (7,633) (4,852) (4,565) 0 0 0
Proceeds from sale of assets 15,407 5,827 24,783 0 0 0 0 0 0 12,146 5,770 19,211 3,261 57 5,572 0 0 0
Return of capital from subsidiaries 0 0 0 0 0 0 683 1,816 (4,943) 0 0 0 0 0 0 (683) (1,816) 4,943
Investment in subsidiaries 0 0   0 0   (9,235) (2,600)   (785) 0   0 0   10,020 2,600  
Changes in restricted cash (303) 60 926 (303) 60 926 0 0 0 0 0 0 0 0 0 0 0 0
Net cash used in investing activities (91,120) (389,054) (51,903) (8,844) (8,091) (2,759) (8,552) (784) (4,943) (77,989) (376,168) (50,151) (5,072) (4,795) 1,007 9,337 784 4,943
Cash flows from financing activities:                                    
Proceeds from issuance of 7.125% senior subordinated notes due 2021 0 93,825 0 0 0   0 93,825   0 0   0 0   0 0  
Proceeds from Term Loan on Senior Credit Agreement 0 125,000 0 0 125,000   0 0   0 0   0 0   0 0  
Proceeds from borrowings on Senior Credit Agreement 502,000 404,500 0 502,000 404,500   0 0   0 0   0 0   0 0  
Principal payments on Senior Credit Agreement (495,813) (358,625) 0 (495,813) (358,625)   0 0   0 0   0 0   0 0  
Debt issuance costs 0 (6,739)   0 (4,158)   0 (2,581)   0 0   0 0   0 0  
Repurchases of common stock (9,999) (15,203) (12,960) (9,999) (15,203) (12,960) 0 0 0 0 0 0 0 0 0 0 0 0
Exercise of stock options and other 14,568 5,253 6,490 14,568 5,253 6,490 0 0 0 0 0 0 0 0 0 0 0 0
Restricted stock tax withholdings (3,781) (884) (329) (3,781) (884) (329) 0 0 0 0 0 0 0 0 0 0 0 0
Excess tax benefit from share-based awards 3,025 1,283 1,625 3,025 1,283 1,625 0 0 0 0 0 0 0 0 0 0 0 0
Principal payments on capital lease obligations and other financing (1,000) (74) (233) 0 0 0 0 0 0 (1,000) (74) (233) 0 0 0 0 0 0
Intercompany funding 0 0 0 (8,355) (156,027) 1,178 20,794 (80,848) 13,717 (13,336) 230,669 (12,484) 10,234 6,990 2,532 (9,337) (784) (4,943)
Net cash provided by financing activities 9,000 248,336 (5,407) 1,645 1,139 (3,996) 20,794 10,396 13,717 (14,336) 230,595 (12,717) 10,234 6,990 2,532 (9,337) (784) (4,943)
Net (decrease) increase in cash and equivalents 2,065 (33,974) 7,815 0 0 0 0 0 0 1,573 (33,397) 6,955 492 (577) 860 0 0 0
CASH AND EQUIVALENTS AT BEGINNING OF PERIOD 18,607 52,581 44,766 0 0 0 0 0 0 18,166 51,563 44,608 441 1,018 158 0 0 0
CASH AND EQUIVALENTS AT END OF PERIOD $ 20,672 $ 18,607 $ 52,581 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 19,739 $ 18,166 $ 51,563 $ 933 $ 441 $ 1,018 $ 0 $ 0 $ 0